A. Matsui

发表

Prediction of catalepsies induced by amiodarone, aprindine and procaine: similarity in conformation of diethylaminoethyl side chain.

Y. Sawada, H. Takanaga, S. Sasaki, 1998, The Journal of pharmacology and experimental therapeutics.

Propiverine-Induced Parkinsonism: A Case Report and a Pharmacokinetic/Pharmacodynamic Study in Mice

Y. Sawada, H. Takanaga, H. Matsuo, 2000, Pharmaceutical Research.

Pancreatic safety in Japanese patients with type 2 diabetes treated with once weekly dulaglutide 0.75 mg up to 52 weeks in phase 3 clinical trials.

M. Emoto, T. Oura, A. Matsui, 2017, Endocrine journal.

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes

E. Araki, N. Inagaki, T. Oura, 2016, Diabetes, obesity & metabolism.

Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes.

T. Oura, M. Takeuchi, Shizuka Kaneko, 2017, Endocrine journal.

Efficacy and safety analyses across 4 subgroups combining low and high age and body mass index groups in Japanese phase 3 studies of dulaglutide 0.75 mg after 26 weeks of treatment.

M. Takeuchi, K. Hamano, A. Matsui, 2017, Endocrine journal.

Beneficial effect of chymostatin on dystrophic mice

A. Matsui, S. Satoh, Keiji Komatsu, 1986, Experimental Neurology.

Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes

T. Oura, A. Matsui, H. Kazama, 2017, Diabetes Therapy.

Pharmacokinetics, Safety, and Tolerability of Atomoxetine and Effect of CYP2D6*10/*10 Genotype in Healthy Japanese Men

K. Desante, J. Azuma, J. Sauer, 2012, Journal of clinical pharmacology.

SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.

Akiko Matsui, Daniel Marzin, Veronique Thybaud, 2006, Mutation research.

In Vivo Gene Expression Profile of Human Intestinal Epithelial Cells: From the Viewpoint of Drug Metabolism and Pharmacokinetics

H. Mizuguchi, T. Yamashita, D. Hirayama, 2020, Drug Metabolism and Disposition.

Analysis of efficacy and safety of dulaglutide 0.75 mg stratified by sex in patients with type 2 diabetes in 2 randomized, controlled phase 3 studies in Japan.

T. Oura, A. Matsui, Y. Onishi, 2017, Endocrine journal.

Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats 3). Effects of repeated doses of ethinylestradiol for 2 and 4 weeks on the male reproductive organs.

A. Matsui, Y. Mera, S. Ogawa, 2000, The Journal of toxicological sciences.

Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial

J. Vekemans, Erika Yoshida, U. Olsson, 2021, International Journal of Infectious Diseases.

Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10.

Y. Kanai, N. Ishiguro, A. Matsui, 2022, Journal of pharmacological sciences.

Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes

Akiko Matsui, Daniel Bischoff, Roderich D Süssmuth, 2018, Drug Metabolism and Disposition.

Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic 2 D Sandwich-Cultures : A Comparative Evaluation of Upcyte and Primary Human Hepatocytes

R. Süssmuth, Gaku Morinaga, G. Schänzle, 2017 .